ArticleCell cycle (Georgetown, Tex.)2012
Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.
Takenori Ogawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it